Precision BioSciences Dividends
| DTIL Stock | USD 4.06 0.30 7.98% |
The value of Dividends Paid is estimated to slide to about 9.9 M. Dividend Paid And Capex Coverage Ratio is expected to rise to -255.4 this year. Precision BioSciences' past performance could be the main factor of why investors trade Precision BioSciences stock today. Investors should clearly understand every aspect of the Precision BioSciences dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Precision BioSciences' dividend schedule and payout information. Precision BioSciences dividends can also provide a clue to the current valuation of Precision BioSciences.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 11.2 M | 9.9 M | |
| Dividend Paid And Capex Coverage Ratio | (268.85) | (255.40) |
Precision | Build AI portfolio with Precision Stock |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Precision BioSciences must own a stock before its ex-dividend date to receive its next dividend.
Precision BioSciences Dividends Paid Over Time
Today, most investors in Precision BioSciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Precision BioSciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Precision BioSciences dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. Projected growth potential of Precision fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Precision BioSciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (8.96) | Revenue Per Share | Quarterly Revenue Growth (0.98) | Return On Assets | Return On Equity |
Precision BioSciences's market price often diverges from its book value, the accounting figure shown on Precision's balance sheet. Smart investors calculate Precision BioSciences' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Precision BioSciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Precision BioSciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Precision BioSciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.